SecBot SecBot
144 ·Filed Nov 12, 2026

LGND

LIGAND PHARMACEUTICALS INC
NEUTRAL
Impact 2/10
Horizondays Processed4d 9h ago SEC0001950047-26-011042
Form 144: notice of proposed sale of securities
Actionable Insight • Neutral

This is a routine director sale of shares acquired through equity compensation. The small size relative to market cap suggests no material insider concern. Monitor for any subsequent Form 4 filings to confirm execution and for any pattern of larger insider selling.

DirectionNeutral
Confidencehigh
Horizondays

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+1
Entry
$308.79
T+0 close · Nov 12, 2026 · via day close
Latest settled
−2.29%
T+1 · $301.71
Vs SPY
−0.38%
α at T+1
Next horizon
T+5
in 3d
  1. T+0 · Nov 13 $308.79entry
  2. T+1 · 19h ago −2.29%α −0.38% · $301.71
  3. T+5 · in 3d Pending
  4. T+20 · in 27d Pending
  5. T+60 · in 3mo Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Director Martine Zimmermann filed a Form 144 notice of intent to sell 2,000 shares of Ligand Pharmaceuticals common stock, with an estimated aggregate market value of approximately $636,336. The shares were acquired through restricted stock grants in 2025 and 2026. This is a routine insider sale by a director and represents a small fraction of the company's market cap.

Key Facts

  • Reporting person: Martine Zimmermann, Director of Ligand Pharmaceuticals
  • Securities to be sold: 2,000 shares of Common Stock
  • Estimated aggregate market value: $636,336.20
  • Shares acquired via restricted stock grants on 06/06/2025 (626 shares), 09/22/2025 (647 shares), and 06/05/2026 (727 shares)
  • Broker: Morgan Stanley Smith Barney LLC Executive Financial Services
  • Proposed sale date: 11/12/2026
  • Exchange: NASDAQ

Financial Impact

Sale of 2,000 shares valued at approximately $636,336, representing a small fraction of the company's market cap.

dilution

Risk Factors

  • Insider sale may signal reduced conviction, though the small size and director role limit concern.
  • Form 144 is an intent to sell; the actual sale may not occur.

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001950047-26-011042
Document: 0001950047-26-011042-index.html0001950047-26-011042
Document: 0001950047-26-011042.txt0001950047-26-011042

Track record

29 reports on LGND

Performance horizon

3 of 3 bullish or bearish reports moved the stock their way by T+60. Best: +38.85% at T+60 after the Apr 14, 2026 report. 4 of 4 went positive at some point.

Filters
  1. Nov 16, 2026today Insider Cluster Neutral 2/10 Entry $305.74 Now $301.71 −1.32% settles Feb 16
  2. Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $306.47 Now $301.71 −1.55% settles Feb 12
  3. Nov 12, 20264d ago 144 Neutral 2/10 Viewing Entry $308.79 Now $301.71 −2.29% settles Feb 11
  4. Nov 12, 20264d ago 144 Neutral 2/10 Entry $308.79 Now $301.71 −2.29% settles Feb 11
  5. Nov 12, 20264d ago 144 Neutral 2/10 Entry $316.27 Now $301.71 −4.60% settles Feb 10
  6. Nov 10, 20266d ago SC 13G/A Neutral 2/10 Entry $316.83 Now $301.71 −4.77% settles Feb 9
  7. Nov 10, 20266d ago 144 Neutral 2/10 Entry $314.16 Now $301.71 −3.96% settles Feb 8
  8. Nov 6, 202610d ago Insider Cluster Neutral 2/10 Entry $314.15 Now $301.71 −3.96% settles Feb 5
  9. Nov 4, 202612d ago 144 Neutral 1/10 Entry $299.00 Now $301.71 +0.91% settles Feb 3
  10. Nov 4, 202612d ago Insider Cluster Neutral 2/10 Entry $299.00 Now $301.71 +0.91% settles Feb 3
Showing 10 of 29

US Market Status

Market Closed · Opens in 7h 28m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 12, 2026